by Team Small News | Jul 9, 2025 | Pharma, Zydus
In a significant development, the Bombay High Court has dismissed a pre-emptive lawsuit filed by Indian pharmaceutical company Zydus Cadila against Swiss multinational company Roche nearly a decade ago. The lawsuit related to Zydus Cadila’s biosimilar version of...
by Team Small News | Jun 9, 2025 | Pharma, Zydus
Agenus Inc., a clinical-stage immuno-oncology company, has partnered with Zydus Lifesciences, a global healthcare company, in a $141 million deal to expand access to its investigational therapies, botensilimab and balstilimab. This partnership aims to accelerate the...
by Team Small News | Jun 7, 2025 | Pharma, Zydus
Agenus Inc., a clinical-stage immuno-oncology company, has partnered with Zydus Lifesciences, a leading Indian pharmaceutical company, in a deal worth up to $141 million to expand access to two of its key pipeline assets, botensilimab and balstilimab. This...
by Team Small News | May 29, 2025 | Pharma, Zydus
Zydus Lifesciences Ltd. has announced that its experimental drug, Usnoflast, has been granted Fast Track Designation by the US Food and Drug Administration (US FDA) for the treatment of amyotrophic lateral sclerosis (ALS). This designation is given to drugs that treat...
by Team Small News | May 24, 2025 | Pharma, Zydus
Zydus Lifesciences has received final approval from the US Food and Drug Administration (USFDA) to launch its isotretinoin capsules in six different strengths. The approval allows the company to produce generic versions of Absorica, a prescription treatment for severe...
by Team Small News | May 22, 2025 | Aurobindo Pharma, Natco, Pharma, Piramal Pharma, Zydus
The Indian pharmaceutical sector has demonstrated robust growth over the past year, driven by a new trade agreement with the European Union that reduces tariffs on key drug exports. This agreement is expected to enhance India’s position as a global supplier of...